The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and safety of mechlorethamine (MCH) 0.04% gel in mycosis fungoides (MF) after treatment with topical MCH 0.02%.
Youn H. Kim
Consultant or Advisory Role - Ceptaris
Research Funding - Ceptaris
Madeleine Duvic
Consultant or Advisory Role - Actelion
Research Funding - Actelion
Joan Guitart
Consultant or Advisory Role - Actelion
Honoraria - Actelion
Stuart Lessin
Consultant or Advisory Role - Actelion
Honoraria - Actelion